Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Therapeutic Implications of the Unusually Long Half-Life of (E)-5-(2-BRO-Movinyl)Uracil (BVUra) in Vivo — Claude Des̀granges (1987) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Therapeutic Implications of the Unusually Long Half-Life of (E)-5-(2-BRO-Movinyl)Uracil (BVUra) in Vivo
Shared by
De Clercq Erik
KU Leuven
Therapeutic Implications of the Unusually Long Half-Life of (E)-5-(2-BRO-Movinyl)Uracil (BVUra) in Vivo
Chapter In A Book
1987
en
Authors
CD
Claude Des̀granges
GR
G Razaka
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1985
Therapeutic Implications of The Unusually Long Half-Life of (E)-5–(2–bromovinyl)uracil (Bvura) In Vivo
Claude Des̀granges
,
G Razaka
,
De Clercq Erik
,
H Bricaud
Article
1985
Inhibition of the degradation of thymine and 5-substituted uracil analogues by (E)-5-(2-bromovinyl)uracil in vivo
Claude Des̀granges
,
G Razaka
,
H Bricaud
,
De Clercq Erik
Article
1984
Inhibition of pyrimidine degradation by (E)-5-(2-bromovinyl)uracil in vivo
Claude Des̀granges
,
G Razaka
,
F Drouillet
,
H Bricaud
,
Piet Herdewijn
,
De Clercq Erik
Article
1986
Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine
De Clercq Erik
,
Claude Des̀granges
,
Piet Herdewijn
,
Iain S. Sim
,
A. S. JONES
,
Michael J. McLean
,
Richard Walker
Article
1986
ChemInform Abstract: Synthesis and Antiviral Activity of (E)‐5‐(2‐Bromovinyl)uracil and (E)‐5‐(2‐Bromovinyl)uridine.
De Clercq Erik
,
Claude Des̀granges
,
Piet Herdewijn
,
Iain S. Sim
,
A. S. JONES
,
Michael J. McLean
,
Richard Walker
Discussion(0)
No comments yet. Be the first to comment.